Pharmacy Focus25 Apr 2024

S2 Ep18: Public Health Matters: Entrepreneurship, MedsPLUS Consulting, and Reaching Marginalized Communities

In this episode, host Dr. Christina Madison interviews Pauline K. Long, PharmD, DCES, pharmacist and co-owner of MedsPLUS Consulting in Birmingham, Alabama. They discuss Dr. Pauline's journey into entrepreneurship, her motivations for opening her own pharmacy, the impact of her consulting business on patient outcomes, and innovative approaches to community health and wellness services, including vaccination clinics and employee wellness programs.

Key Takeaways:

Dr. Pauline Long's journey into entrepreneurship highlights the opportunities for pharmacists to make a significant impact beyond traditional roles. By starting her own pharmacy and consulting business, she demonstrates how pharmacists can innovate and address unmet needs within their communities.
Dr. Pauline's approach emphasizes the importance of community-centered care and culturally competent services. Through strategic partnerships with health care providers and community organizations, she works to improve patient outcomes and address health disparities, particularly in marginalized communities.
Utilizing local resources, grants, and community support is essential for implementing innovative health initiatives. Dr. Pauline’s experience demonstrates the value of networking, seeking mentorship, and accessing resources such as the Small Business Administration to support pharmacy entrepreneurs in navigating obstacles and maximizing impact.Dr. Pauline K. Long can be found on LinkedIn.

To learn more about MedsPLUS Consulting, LLC, check out their website, call 205-650-4636, or reach out to Dr. Pauline via email at drpauline@medsplusconsulting.com. Check out MedsPLUS on their social media channels:

Facebook: @Medsplus Consulting
Instagram: @medsplus_consulting
TikTok: @medsplus
LinkedIn: MedsPLUS Consulting

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(356)

S2 Ep92: Beyond CRS and ICANS: Managing the Delayed Toxicities of Cilta-cel

Sara Scott, PharmD, BCOP, Emma Uchida, PharmD, MBA, BCOP, and Rebecca Gonzalez, PharmD, BCOP, gather for a roundtable on the rare, delayed toxicities associated with ciltacabtagene autoleucel in relap...

28 Aug 50min

S2 Ep91: Food, Fungals, and Flexibility: Real-World Dosing of Revumenib

26 Aug 25min

S2 Ep90: Introducing the Psychiatric Pharmacist Pulse Podcast

Megan Maroney, PharmD, BCPP, FAAPP: Hello, I'm Megan Maroney, and this is Psychiatric Pharmacy Pulse, a monthly podcast where we talk about hot topics in psychiatric pharmacy. I'm a clinical associate...

21 Aug 1min

S2 Ep89: Under the Skin: What Subcutaneous Isatuximab Means for Myeloma Care

Matthew Lei, PharmD, BCOP, a clinical oncology pharmacist at Massachusetts General Hospital, joins Pharmacy Focus: Oncology Edition to break down the FDA approval of subcutaneous isatuximab-irfc via t...

20 Aug 31min

S2 Ep88: CMSC 2026 Highlights: Biomarkers, DMT Discontinuation, and Pregnancy Planning in MS

In this episode of Mind the Meds, host Erica Marini, PharmD, MS, BCPS, welcomes Jenelle Hall Montgomery, PharmD, BCACP, CPP, a clinical pharmacist practitioner with Duke Neurological Disorders Clinic ...

6 Aug 54min

S2 Ep87: EP. 1: Introducing Pharmacy Focus: Financial Wellness—Building Your Rich Life

Have a question, feedback, or an idea for a future episode? Contact YFP Wealth at info@yfpwealth.com. To learn more about fee-only financial planning services for pharmacists, visit yfpwealth.com.This...

3 Aug 10min

S2 Ep86: Untangling Holistic, Integrative, Functional, and Precision Medicine in Oncology

Holistic, integrative, functional, precision—the labels are everywhere, but few patients or clinicians know where one ends and the next begins.

24 Juli 37min

S2 Ep84: Beyond Seizures: Phenobarbital's Clinically Significant Interaction Profile

To open the episode, Erica Marini, PharmD, discussed a roundup of FDA and research updates in neurology. She covered the shifting accelerated-approval pathway for AMT-130 (uniQure), a gene therapy for...

2 Juli 53min